{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:21:43Z","timestamp":1791102103034,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001869","type":"journal-article","created":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T21:15:07Z","timestamp":1351804507000},"page":"e1869","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Human Beta-Defensin 3 Is Up-Regulated in Cutaneous Leprosy Type 1 Reactions"],"prefix":"10.1371","volume":"6","clinical-trial-number":[{"clinical-trial-number":"isrctn31894035","registry":"10.18810\/isrctn"}],"author":[{"given":"Anna L.","family":"Cogen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrissy H.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna A.","family":"Hagge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil D.","family":"Neupane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraswoti","family":"Khadge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana N. J.","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,1]]},"reference":[{"key":"ref1","article-title":"WHO Status Report","year":"2009"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1126\/science.1925582","article-title":"Defining protective responses to pathogens: cytokine profiles in leprosy lesions","volume":"254","author":"M Yamamura","year":"1991","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2009.11.008","article-title":"TLR2 looks at lipoproteins","volume":"31","author":"M Schenk","year":"2009","journal-title":"Immunity"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nm864","article-title":"Activation and regulation of Toll-like receptors 2 and 1 in human leprosy","volume":"9","author":"SR Krutzik","year":"2003","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e5810","DOI":"10.1371\/journal.pone.0005810","article-title":"Convergence of IL-1beta and VDR activation pathways in human TLR2\/1-induced antimicrobial responses","volume":"4","author":"PT Liu","year":"2009","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/IAI.00078-10","article-title":"Severity of Staphylococcus aureus infection of the skin is associated with inducibility of human beta-defensin 3 but not human beta-defensin 2","volume":"78","author":"P Zanger","year":"2010","journal-title":"Infect Immun"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e9737","DOI":"10.1371\/journal.pone.0009737","article-title":"Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms","volume":"5","author":"A Seidel","year":"2010","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1039\/c1np00022e","article-title":"Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation","volume":"28","author":"M Wilmes","year":"2011","journal-title":"Nat Prod Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/AAC.50.1.324-331.2006","article-title":"Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides","volume":"50","author":"S Vylkova","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1128\/AAC.50.4.1433-1441.2006","article-title":"Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells","volume":"50","author":"M Boniotto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/IAI.55.3.680-685.1987","article-title":"Intracellular fate of Mycobacterium leprae in normal and activated mouse macrophages","volume":"55","author":"LD Sibley","year":"1987","journal-title":"Infect Immun"},{"key":"ref12","first-page":"30","article-title":"Mycobacterium leprae found in epidermal cells by electron microscopy","volume":"46","author":"S Okada","year":"1978","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jdermsci.2007.01.006","article-title":"Recombinant Mycobacterium leprae protein associated with entry into mammalian cells of respiratory and skin components","volume":"46","author":"N Sato","year":"2007","journal-title":"J Dermatol Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-3083.1993.tb01663.x","article-title":"HLA class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells","volume":"37","author":"T Mutis","year":"1993","journal-title":"Scand J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/35106587","article-title":"Innate antimicrobial peptide protects the skin from invasive bacterial infection","volume":"414","author":"V Nizet","year":"2001","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.meegid.2009.03.006","article-title":"SNP 668C (-44) alters a NF-kappaB1 putative binding site in non-coding strand of human beta-defensin 1 (DEFB1) and is associated with lepromatous leprosy","volume":"9","author":"E Prado-Montes de Oca","year":"2009","journal-title":"Infect Genet Evol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.4049\/jimmunol.170.7.3451","article-title":"Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling","volume":"170","author":"PY Bochud","year":"2003","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1574-695X.2001.tb01586.x","article-title":"Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients","volume":"31","author":"TJ Kang","year":"2001","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1086\/524688","article-title":"Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy","volume":"197","author":"PY Bochud","year":"2008","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/cyto.2002.1982","article-title":"A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy","volume":"20","author":"TJ Kang","year":"2002","journal-title":"Cytokine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2567.2004.01926.x","article-title":"Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation","volume":"112","author":"TJ Kang","year":"2004","journal-title":"Immunology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10096-009-0746-0","article-title":"Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy","volume":"28","author":"PY Bochud","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.20051782","article-title":"TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis","volume":"202","author":"A Bafica","year":"2005","journal-title":"J Exp Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa0903753","article-title":"Genomewide association study of leprosy","volume":"361","author":"FR Zhang","year":"2009","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.chom.2009.09.002","article-title":"Divergence of macrophage phagocytic and antimicrobial programs in leprosy","volume":"6","author":"D Montoya","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e1041","DOI":"10.1371\/journal.pntd.0001041","article-title":"A Phase Two Randomised Controlled Double Blind Trial of High Dose Intravenous Methylprednisolone and Oral Prednisolone versus Intravenous Normal Saline and Oral Prednisolone in Individuals with Leprosy Type 1 Reactions and\/or Nerve Function Impairment","volume":"5","author":"SL Walker","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1128\/IAI.69.5.3413-3417.2001","article-title":"Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment","volume":"69","author":"D Little","year":"2001","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"DM Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.47276\/lr.81.1.41","article-title":"The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3\u2013Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT","volume":"81","author":"VP Shetty","year":"2010","journal-title":"Lepr Rev"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.149.4.1470","article-title":"Cytokine patterns of immunologically mediated tissue damage","volume":"149","author":"M Yamamura","year":"1992","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.molimm.2004.11.001","article-title":"Correlation between beta-defensin expression and induction profiles in gingival keratinocytes","volume":"42","author":"S Joly","year":"2005","journal-title":"Mol Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrmicro2537","article-title":"The skin microbiome","volume":"9","author":"EA Grice","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/jid.2009.243","article-title":"Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin","volume":"130","author":"AL Cogen","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm.2062","article-title":"Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury","volume":"15","author":"Y Lai","year":"2009","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.270.5234.286","article-title":"Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis","volume":"270","author":"N Auphan","year":"1995","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.icb.7100098","article-title":"Coordinating TLR-activated signaling pathways in cells of the immune system","volume":"85","author":"A Banerjee","year":"2007","journal-title":"Immunol Cell Biol"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T13:52:36Z","timestamp":1687787556000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001869"}},"subtitle":[],"editor":[{"given":"Charles L.","family":"Jaffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001869","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,1]]}}}